EDAP TMS(EDAP) - 2023 Q2 - Earnings Call Transcript

Company Participants In closing, we remain optimistic about the remainder of 2023. And I would like to thank the entire EDAP team for their dedication and hard work that is driving increased awareness amongst clinicians and patients of Focal One HIFU as an important and growing treatment option for prostate cancer management. We look forward to sharing our progress with you again in the fall. And I will now turn it back over to the operator for questions. Operator? Question-and-Answer Session Operator [Oper ...